Head-to-head verdict
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.
One of the rare programs offering an oral/sublingual route on both molecules with all-inclusive pricing — but the verdict marks it down hard because the numbers are company-stated, not independently verified.
Visit Direct MedsA coaching-first program with aggressive, identical pricing on both molecules.
Visit FoundFound takes it with a higher Verdict Score — 88/100 to 82/100 (grade B+ vs B−). People who want behavior-change coaching bundled with medication. Direct Meds still earns its place — needle-averse patients who specifically want a sublingual GLP-1 option and are willing to vet a newer operator themselves.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
| Metric | Direct Meds | Found |
|---|---|---|
| Verdict Score | 82/100 | 88/100 |
| Grade | B− | B+ |
| Semaglutide | $179/mo | $129/mo |
| Tirzepatide | $224/mo | $129/mo |
| Coverage | Not publicly listed | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | No |
What we like
The caveats
What we like
The caveats
Also worth a look
Needle-averse patients who specifically want a sublingual GLP-1 option and are willing to vet a newer operator themselves.
Visit Direct Meds Read the full Direct Meds review →Our pick — visit
People who want behavior-change coaching bundled with medication.
Visit Found Read the full Found review →Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.